Sustained remission with the kinase inhibitor sorafenib in stage IV metastatic adrenocortical carcinoma.
Sustained remission with the kinase inhibitor sorafenib in stage IV metastatic adrenocortical carcinoma. Endocr Pract. 2010 May-Jun; 16(3):441-5.